GlaxoSmithKline news from FierceHealthcare
News
Glaxo stops funding commercial CME; Merck funding $150M non-profit vaccine developer;
> In another sign that drugmakers want to reduce their exposure to payola allegations, GlaxoSmithKline has announced that it will stop funding commercial continuing medical education programs.... Read more...
Case study: Miami drug reps not registering as lobbyists
Right now, sentiment is high on Capitol Hill to expose the money flowing to doctors from pharmaceutical and medical device companies. A look at what's happening in some markets right now, however,... Read more...
Pfizer will disclose payments to health professionals
Pfizer has announced that it plans to make data on payments to healthcare professionals publicly available starting in early 2010, including not only physicians, but also researchers and research... Read more...
Emory punishes psychiatrist Nemeroff for drug company ties
Internationally known psychiatrist Dr. Charles Nemeroff is facing serious consequences for taking payments from pharmaceutical companies. Emory University has permanently stripped him of his... Read more...
More objections to Avandia suppressed by Glaxo
We haven't heard anything for a while about Avandia, GlaxoSmithKline's diabetes drug that has been linked to a higher risk of heart attacks, but that doesn't mean no one has been paying attention.... Read more...
Emory psychiatrist accused of not reporting drug company income
A high-profile Emory University psychiatrist has been accused of failing to report one-third of the $2.8 million in consulting fees he received from companies whose drugs he was evaluating, according... Read more...
Glaxo to report grants to U.S. healthcare groups
Bowing to emerging trends favoring such disclosures, drugmaker GlaxoSmithKline has announced plans to publicly report the grants it provides to U.S. healthcare organizations. The report, which will... Read more...
Did Glaxo conceal Paxil users' risk of suicide?
Did drugmaker GlaxoSmithKline conceal suicide risks for users of its antidepressant Paxil within the mountains of data it submitted to the FDA? That's a question Sen. Chuck Grassley (R-Iowa) would... Read more...
ALSO NOTED: U of Miami suffers massive patient data loss; Loyola U sets $1B strategic plan; and much more...
> The University of Miami School of Medicine has lost data backup tapes containing data on 2.1 million patients. Read more...
FDA says Glaxo didn't report Avandia data
According to a new letter from the agency, GlaxoSmithKline didn't turn over post-marketing data about Avandia to the FDA, a lack of disclosure that looks pretty unfortunate given subsequent reports... Read more...
